Skip to main content

Arcturus Therapeutics Holdings Inc.

ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768224

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ARCT: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1572139−16
Shares19.1M40.0K20.0M+929.9K (+4.9%)
Value$909.0M$1.91M$736.2M−$170.9M (−18.8%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (19)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ARCT in Q4 2021
InstitutionSharesValue% of portfolio
Dimensional Fund Advisors LP74,939$2.77M0.00%
Wellington Management Group LLP50,790$1.88M0.00%
Jump Financial, LLC30,443$1.13M0.07%
Renaissance Technologies LLC26,687$988.0K0.00%
Group One Trading, L.P.20,059$742.0K0.01%
Ensign Peak Advisors, Inc7,040$261.0K0.00%
Landscape Capital Management, L.L.C.6,000$222.0K0.03%
Trexquant Investment LP5,939$220.0K0.01%
Northwestern Mutual Wealth Management Co4,265$158.0K0.00%
Byrne Asset Management LLC3,090$114.0K0.07%
High Net Worth Advisory Group LLC1,500$56.0K0.02%
KRS Capital Management, LLC1,400$51.0K0.04%
Allspring Global Investments Holdings, LLC885$32.0K0.00%
Larson Financial Group LLC340$13.0K0.00%
JNBA Financial Advisors170$6.00K0.00%
National Bank of Canada120$4.00K0.00%
TD Waterhouse Canada Inc.85$3.27K0.00%
Evoke Wealth, LLC58$2.00K0.00%
Concord Wealth Partners3$00.00%

Sold out (35)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (2)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARCT in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.39,972$1.91M
Berman Capital Advisors, LLC13$0